Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.38 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL413049 | 0.85 | LMNA (0.35) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL6831031 | 0.84 | — | — | |
| SCHEMBL27857307 | 0.84 | — | — | |
| SCHEMBL3110359 | 0.84 | — | — | |
| SCHEMBL967913 | 0.84 | — | — | |
| SCHEMBL21848016 | 0.82 | FFAR3 (0.33) | FFAR3ALDH1A1 | |
| SCHEMBL14516825 | 0.80 | — | — | |
| SCHEMBL576726 | 0.80 | — | — | |
| SCHEMBL8497865 | 0.79 | — | — | |
| SCHEMBL970315 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117126090-A | Impurity removal method for 5,6-trans impurities in calcitol bulk drug | 正大制药（青岛）有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-113444041-B | Method for synthesizing polysubstituted quinoline compound by photocatalysis | 安徽理工大学 | 2023-10-03 | — | — | CN | claimed |
| EP-4183391-A1 | PHARMACEUTICAL COMPOSITION AND USE THEREOF | Shenzhen Salubris Pharmaceuticals Co., Ltd. (CN) | 2023-05-24 | — | — | EP | claimed |
| CN-115557888-A | Method for preparing quinoline derivative by photocatalysis of N-aryl glycine ester | 安徽理工大学 | 2023-01-03 | — | — | CN | claimed |
| CN-114149444-B | Method for synthesizing 2,3,6,7-anthracene tetracarboxylic dianhydride | 常州市阳光药业有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-108546224-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-108530243-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-114149444-A | Synthesis method of 2,3,6, 7-anthracene tetracarboxylic dianhydride | 常州市阳光药业有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-108530244-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113956129-A | Method for purifying limonene | 福建桦智工程技术有限公司 | 2022-01-21 | — | — | CN | claimed |
| US-9382205-B2 | Processes for the manufacture of a pharmaceutically active agent | H. LUNDBECK A/S (DK) | 2016-07-05 | — | — | US | claimed |
| US-20150080584-A1 | PROCESSES FOR THE MANUFACTURE OF A PHARMACEUTICALLY ACTIVE AGENT | H. LUNDBECK A/S (DK) | 2015-03-19 | — | — | US | claimed |
| US-7727677-B2 | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES, LTD. (JP) | 2010-06-01 | — | — | US | claimed |
| EP-1758198-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2009-07-08 | — | — | EP | claimed |
| CN-100502135-C | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2009-06-17 | — | — | CN | claimed |
| US-20080038644-A1 | Nonaques Electrolyte Solution And Lithium Secondary Battery Using Same | UBE INDUSTRIES, LTD. (JP) | 2008-02-14 | — | — | US | claimed |
| CN-1961452-A | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES (JP) | 2007-05-09 | — | — | CN | claimed |
| EP-1758198-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2007-02-28 | — | — | EP | claimed |
| US-7153816-B2 | Dishwasher detergent with improved protection against glass corrosion | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2006-12-26 | — | — | US | claimed |
| US-20050075258-A1 | Dishwasher detergent with improved protection against glass corrosion | HENKEL AG & CO. KGAA (DE) | 2005-04-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080584-A1 | PROCESSES FOR THE MANUFACTURE OF A PHARMACEUTICALLY ACTIVE AGENT | CEL, DCPS, HPSE | LMNA 3723/4885LDHA 1224/4885SRR 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.